Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma

Statistics

M.. Pereira Barbosaa, A.. Bugalho de Almeidab, C.. Pereirac,

Corresponding author

catarina.pereira@novartis.com

Corresponding author. catarina.pereira@novartis.com

, C.-W. Chend, P.. Georgioue, G.. Peacheye

a Serviço de Imunoalergologia, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal

b Clínica Universitária de Pneumologia, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal

c Novartis Farma – Produtos Farmaceuticos S.A., Avenida Professor Doutor Cavaco Silva, n.° 10E, Taguspark, 2740-255 Porto Salvo, Portugal

d Novartis Pharmaceuticals Corporation, One Health Plaza East Hanover, NJ 07936-1080, USA

e Novartis Pharmaceuticals UK Limited, Wimblehurst Road Horsham, West Sussex RH12 5AB, UK

Read

8674

Times
was read the article

2589

Total PDF

6085

Total HTML

Share statistics

Article information

ISSN: 08732159
Original language: English

DOI:10.1016/j.rppnen.2014.07.004

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 December	33	19	52
2024 November	66	45	111
2024 October	62	32	94
2024 September	64	25	89
2024 August	69	29	98
2024 July	51	35	86
2024 June	61	23	84
2024 May	45	31	76
2024 April	57	26	83
2024 March	60	31	91
2024 February	48	24	72
2024 January	41	24	65
2023 December	34	29	63
2023 November	46	30	76
2023 October	42	43	85
2023 September	31	29	60
2023 August	40	22	62
2023 July	40	27	67
2023 June	38	16	54
2023 May	64	23	87
2023 April	40	14	54
2023 March	80	22	102
2023 February	58	21	79
2023 January	47	22	69
2022 December	68	20	88
2022 November	92	39	131
2022 October	55	43	98
2022 September	34	27	61
2022 August	51	35	86
2022 July	48	50	98
2022 June	40	35	75
2022 May	47	35	82
2022 April	32	32	64
2022 March	43	45	88
2022 February	47	39	86
2022 January	31	35	66
2021 December	38	33	71
2021 November	36	43	79
2021 October	43	41	84
2021 September	31	34	65
2021 August	29	25	54
2021 July	27	13	40
2021 June	26	25	51
2021 May	33	26	59
2021 April	100	55	155
2021 March	73	18	91
2021 February	53	19	72
2021 January	34	11	45
2020 December	32	9	41
2020 November	39	23	62
2020 October	39	16	55
2020 September	59	28	87
2020 August	79	24	103
2020 July	100	22	122
2020 June	94	14	108
2020 May	100	22	122
2020 April	85	5	90
2020 March	84	9	93
2020 February	75	26	101
2020 January	89	19	108
2019 December	93	14	107
2019 November	86	14	100
2019 October	88	25	113
2019 September	77	28	105
2019 August	107	8	115
2019 July	137	19	156
2019 June	143	19	162
2019 May	121	8	129
2019 April	118	32	150
2019 March	187	16	203
2019 February	187	6	193
2019 January	167	26	193
2018 December	81	4	85
2018 November	49	0	49
2018 October	51	11	62
2018 September	19	12	31
2018 August	43	23	66
2018 July	31	16	47
2018 June	33	17	50
2018 May	47	25	72
2018 April	44	18	62
2018 March	54	19	73
2018 February	15	14	29
2018 January	18	14	32
2017 December	21	32	53
2017 November	18	19	37
2017 October	17	18	35
2017 September	21	16	37
2017 August	24	8	32
2017 July	18	6	24
2017 June	25	21	46
2017 May	24	23	47
2017 April	11	7	18
2017 March	27	11	38
2017 February	9	11	20
2017 January	12	7	19
2016 December	10	9	19
2016 November	8	3	11
2016 October	5	3	8
2016 September	1	0	1
2016 August	6	4	10
2016 July	4	8	12
2016 June	0	5	5
2016 May	1	6	7
2016 April	19	1	20
2016 March	47	17	64
2016 February	41	26	67
2016 January	22	13	35
2015 December	26	12	38
2015 November	18	17	35
2015 October	26	31	57
2015 September	51	21	72
2015 August	55	40	95
2015 July	54	28	82
2015 June	69	36	105
2015 May	196	105	301

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter